Position in NAMS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$58,443,915
-$32,195,825 QoQ
Shares Held
1,724,518
-39.1% QoQ
Ownership
1.44%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#15
of 198 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Derivatives in NAMS
reported options exposure · as of Dec 31, 2023CallValue
$10,161,818
CallShares
909,742
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Polar Capital Holdings Plc holds $3,774,805,029 across 41 Biotechnology names. NAMS ranks #27 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELVN |
Enliven Therapeutics, Inc.
|
6,430,636 | $326,354,777 | |
| 2 | XENE |
Xenon Pharmaceuticals Inc.
|
4,570,556 | $275,878,760 | |
| 3 | CYTK |
Cytokinetics Inc
|
2,253,649 | $191,988,358 | |
| 4 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,663,632 | $184,713,060 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
|
6,606,945 | $173,234,097 | |
| 6 | ASND |
Ascendis Pharma A/S
|
616,908 | $164,541,701 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
2,063,609 | $153,697,598 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
482,751 | $145,322,533 |
All Filings in NAMS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $58,443,915 | 1,724,518 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $90,639,740 | 2,831,607 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $97,389,867 | 2,776,222 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $82,806,870 | 2,911,634 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $45,596,977 | 2,517,779 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $46,057,500 | 2,250,000 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $44,975,000 | 1,750,000 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $24,983,000 | 1,505,000 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $19,259,677 | 1,002,586 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $29,623,658 | 1,252,586 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $10,161,818 | 909,742 | Call | Defined | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||